Skip to Content
Merck

Stereoselective Synthesis of HIV-1 Protease Inhibitor, DMP 323.

The Journal of organic chemistry (1996-01-26)
Michael E. Pierce, Gregory D. Harris, Qamrul Islam, Lilian A. Radesca, Louis Storace, Robert E. Waltermire, Ed Wat, Prabhakar K. Jadhav, George C. Emmett
ABSTRACT

DMP 323, a potent HIV-1 protease inhibitor, has been synthesized by an efficient stereoselective process, amenable to large scale preparations. The core C(2) symmetric diol was synthesized by a stereoselective pinacol coupling of CBZ protected D-phenylalanine. Judicious selection of protecting groups allowed cyclic urea formation under mild conditions, enhanced the ease of bis-alkylation, and led to intermediates which were easily purified without chromatography. Additionally, a one-pot, high yield process was developed to prepare the alkylating agent, 4-[(triphenylmethoxy)methyl]benzyl chloride from 1,4-benzenedimethanol.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Z-L-Phenylalaninol, 97%
Sigma-Aldrich
(S)-(+)-2-(Dibenzylamino)-1-propanol, 99%
Sigma-Aldrich
(S)-(+)-2-(Dibenzylamino)-3-phenyl-1-propanol, 99%